Date of Release: February 15, 2017 Expiration Date: November 25, 2022
Estimate Time of Completion: 1 hour
Learning objectives
At the conclusion of the series, participants should be able to:
Session learning objectives
At the conclusion of this session, participants should be able to:
Continuing Education Information:
CONTINUING MEDICAL EDUCATION (CME)
The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation:
The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CONTENT VALIDATION AND FAIR BALANCE
ACMG follows the ACCME policy on Content Validation for CME activities, which requires: a)All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. b) All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis. Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients. Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality. If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.
HIPAA COMPLIANCE BY FACULTY
The ACMG supports medical information privacy. While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized. All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information. If so, they were asked either to attest that a HIPAA-compliant consent form is on file at their institution, or to send ACMG a copy of the ACMG HIPAA compliance form. This information is on record at the ACMG Administrative Office and will be made available upon request.
FINANCIAL DISCLOSURES
Planning Committee
Monica Giovanni, MS, CGC
Geisinger Health System, Brookline, MA
Nothing to disclose
Liming Bao, MD, PhD, FACMG
Dartmouth-Hitchcock Medical Center
Christian Schaaf, MD, PhD, FACMG
Baylor College of Medicine and Jan & Dan Duncan Neurological Research Institute, Houston, TX
Staff - American College of Medical Genetics and Genomics
Jane Radford, MHA, CHCP
Michael Watson, PhD, FACMG
Presenters and Disclosures
The following have nothing to disclose.
Julie Jones, PhD, FACMG, Director, Clinical Genomic Sequencing Program
Catherine J. Spellicy, PhD, Clinical Molecular Genetics Laboratory Fellow
Jennifer Anne Lee, PhD, FACMG, Lead Director, Molecular Diagnostic Laboratory
Katarzyna (Kasia) Ellsworth, PhD, Clinical Molecular Genetics Laboratory Fellow
© 2022 American College of Medical Genetics and Genomics. All rights reserved.